These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 25405790)
21. Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma. Yang Y; Zhang N; Zhu J; Hong XT; Liu H; Ou YR; Su F; Wang R; Li YM; Wu Q Int J Oncol; 2017 Jun; 50(6):1977-1988. PubMed ID: 28498415 [TBL] [Abstract][Full Text] [Related]
22. ZnAs@SiO Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768 [No Abstract] [Full Text] [Related]
23. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma. Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN. Zhang QY; Men CJ; Ding XW J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454 [TBL] [Abstract][Full Text] [Related]
25. M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway. Yao RR; Li JH; Zhang R; Chen RX; Wang YH World J Surg Oncol; 2018 Jan; 16(1):9. PubMed ID: 29338742 [TBL] [Abstract][Full Text] [Related]
26. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma. Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761 [TBL] [Abstract][Full Text] [Related]
27. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375. Li L; Xiao C; He K; Xiang G IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288 [TBL] [Abstract][Full Text] [Related]
28. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858 [TBL] [Abstract][Full Text] [Related]
29. PAK1 promotes proliferation, migration and invasion of hepatocellular carcinoma by facilitating EMT via directly up-regulating Snail. Cao F; Yin LX Genomics; 2020 Jan; 112(1):694-702. PubMed ID: 31071459 [TBL] [Abstract][Full Text] [Related]
30. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma. Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955 [TBL] [Abstract][Full Text] [Related]
31. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906 [TBL] [Abstract][Full Text] [Related]
32. Lack of hepatic stimulator substance expression promotes hepatocellular carcinoma metastasis partly through ERK-activated epithelial-mesenchymal transition. Jia XW; Li ZW; Dong LY; Sun GY; Wang X; Gao J; Li YP; Wu Y; An W Lab Invest; 2018 Jul; 98(7):871-882. PubMed ID: 29497174 [TBL] [Abstract][Full Text] [Related]
33. HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL. Zhou ZJ; Dai Z; Zhou SL; Hu ZQ; Chen Q; Zhao YM; Shi YH; Gao Q; Wu WZ; Qiu SJ; Zhou J; Fan J Cancer Res; 2014 May; 74(10):2750-62. PubMed ID: 24638979 [TBL] [Abstract][Full Text] [Related]
34. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581 [TBL] [Abstract][Full Text] [Related]
35. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells. Yang L; Chang Y; Cao P Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147 [TBL] [Abstract][Full Text] [Related]
36. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma. Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864 [TBL] [Abstract][Full Text] [Related]
37. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling. Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830 [TBL] [Abstract][Full Text] [Related]
38. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. Yin Z; Ma T; Lin Y; Lu X; Zhang C; Chen S; Jian Z J Cell Biochem; 2018 Nov; 119(11):9419-9432. PubMed ID: 30015355 [TBL] [Abstract][Full Text] [Related]
39. RMP promotes epithelial-mesenchymal transition through NF-κB/CSN2/Snail pathway in hepatocellular carcinoma. Zhou W; Wang Q; Xu Y; Jiang J; Guo J; Yu H; Wei W Oncotarget; 2017 Jun; 8(25):40373-40388. PubMed ID: 28423737 [TBL] [Abstract][Full Text] [Related]
40. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells. Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]